Management of Patients Using Oral Anticoagulant Agent in Dental Practice
Journal Title: Bezmiâlem Science - Year 2019, Vol 7, Issue 3
Abstract
An increasing number of patients in our country use oral anticoagulants for the prophylaxis and treatment of thromboembolic events. The cornerstone of these groups of agents is warfarin, a vitamin K antagonist, which has been the single alternative used by oral route for several years. However, due to warfarin’s late onset and long lasting action and the intense interactions with food and drugs, newer oral anticoagulants have emerged in the market in recent years. Dabigatran, rivaroxaban and apixaban are the novel agents used in our country. Those drugs should be regulated in the perioperative period when patients receiving oral anticoagulants are referred for dental interventions. The interruption of agents may result in lethal consequences of thromboembolic events, while continuing raises the risk of bleeding. This review outlines the various properties of the oral anticoagulants and the most recent recommendations and guidelines regarding the management of dental patients taking these medications.
Authors and Affiliations
Özge DOĞANAY, Türker YÜCESOY, Alper ALKAN
Keywords
Related Articles
- EP ID EP50753
- DOI 10.14235/bas.galenos.2018.2199
- Views 213
- Downloads 0
Current Approaches in Premenstrual Syndrome Management
Premenstrual syndrome (PMS) is a health problem that occurs with physical and psychological symptoms presenting about five days before menstruation, end within a few days after the onset of menstruation. The most common...
New Diagnosis Diabetes and Deep Venous Thrombosis with Glucagonoma Cases; Case Report
Glucagonomas; is a rare neuroendocrine tumor originating from alpha cells of the pancreas. Glucagonoma syndrome is a paraneoplastic entity known as diarrhea, weight loss, stomatitis, thrombosis, diabetes, and necrotizing...
Effects of 18-month Vildagliptin Treatment on Portal Vein Pressure and Hepatosteatosis
Objective: Patients with type 2 diabetes have an increased tendency to develop hepatosteatosis. The effects of drugs used to treat diabetes on the liver, regardless of the disease, are unknown.The aim of this study was t...
Effect of Flavopiridol on Cell Cycle, Apoptosis and Biomolecule Structure Changes in Breast Cancer Stem Cells
Objective: Cancer stem cells (CSCs) are a small population in cancer, which are responsible for therapeutic resistance, relapse and metastasis. Flavopiridol has antitumor activity against various types of cancer cells. T...
A Liquid Chromatographic Analysis of Gemifloxacin in Pharmaceutical Preparations Using 4-bromomethyl-7-methoxycoumarin Reagent
Objective: In this study, analysis of gemifloxacin in pharmaceutical preparations was performed in the presence of 4-bromomethyl-7- methoxycoumarin reagent and dibenzo-18-crown-6 ether catalyst, by high-performance liqui...